CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer
CRISPR/Cas9 筛选鉴定出 LIG1 是去势抵抗性前列腺癌中 PARP 抑制剂的敏化剂
期刊:Journal of Clinical Investigation
影响因子:13.3
doi:10.1172/JCI179393
Giulia Fracassi, Francesca Lorenzin, Francesco Orlando, Ubaldo Gioia, Giacomo D'Amato, Arnau S Casaramona, Thomas Cantore, Davide Prandi, Frédéric R Santer, Helmut Klocker, Fabrizio d'Adda di Fagagna, Joaquin Mateo, Francesca Demichelis
